Androgen Receptor Roles in Benign and Malignant Prostate Disease

Androgen deprivation therapy (ADT), which aims to reduce androgen–androgen receptor (AR) signaling, is the normal method of prostate cancer treatment. Despite its early success in suppressing prostate tumor growth, the therapy eventually fails, leading to recurrent hormone-refractory tumor growth. R...

Täydet tiedot

Bibliografiset tiedot

Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	China Anti-Cancer Association 2011-06-01
Sarja:	Cancer Biology & Medicine
Aiheet:	prostate prostate cancer androgen receptor androgen replacement therapy
Linkit:	http://www.cancerbiomed.org/index.php/cocr/article/view/49
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!